These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 19422482)

  • 1. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
    Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
    Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis.
    Latella G; Vetuschi A; Sferra R; Zanninelli G; D'Angelo A; Catitti V; Caprilli R; Flanders KC; Gaudio E
    Eur J Clin Invest; 2009 Feb; 39(2):145-56. PubMed ID: 19200168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation.
    Sferra R; Vetuschi A; Catitti V; Ammanniti S; Pompili S; Melideo D; Frieri G; Gaudio E; Latella G
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1484-98. PubMed ID: 23111960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis.
    Sferra R; Vetuschi A; Pompili S; Gaudio E; Speca S; Latella G
    Pathol Res Pract; 2017 Jan; 213(1):58-65. PubMed ID: 27894619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
    Xu W; Song S; Huang Y; Gong Z
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression.
    Choi HK; Pokharel YR; Lim SC; Han HK; Ryu CS; Kim SK; Kwak MK; Kang KW
    Toxicol Appl Pharmacol; 2009 Nov; 240(3):377-84. PubMed ID: 19647758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad3-null mice lack interstitial cells of Cajal in the colonic wall.
    Vetuschi A; Sferra R; Latella G; D'Angelo A; Catitti V; Zanninelli G; Continenza MA; Gaudio E
    Eur J Clin Invest; 2006 Jan; 36(1):41-8. PubMed ID: 16403009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the involvement of TGF-β1-CTGF axis in liver fibrogenesis secondary to hepatic viral infection.
    Tache D; Bogdan F; Pisoschi C; Baniţă M; Stănciulescu C; Fusaru AM; Comănescu V
    Rom J Morphol Embryol; 2011; 52(1 Suppl):409-12. PubMed ID: 21424084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice.
    George J; Tsutsumi M; Tsuchishima M
    J Cell Mol Med; 2017 Dec; 21(12):3821-3835. PubMed ID: 28782260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats.
    Yasuda H; Imai E; Shiota A; Fujise N; Morinaga T; Higashio K
    Hepatology; 1996 Sep; 24(3):636-42. PubMed ID: 8781336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
    Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
    Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of perindopril and valsartan on the expression of TGF beta 1 and TGF beta receptor II mRNA, Smad3 and Smad7 in experimental hepatic fibrotic rats].
    Gong ZJ; Song SL; Huang YQ; Ruan P
    Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):737-40. PubMed ID: 15619341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.
    Kuriyama S; Yokoyama F; Inoue H; Takano J; Ogawa M; Kita Y; Yoshiji H; Deguchi A; Kimura Y; Himoto T; Yoneyama H; Kurokohchi K; Masaki T; Uchida N; Watanabe S
    Int J Mol Med; 2007 Feb; 19(2):317-24. PubMed ID: 17203207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased iron deposition in rat liver fibrosis induced by a high-dose injection of dimethylnitrosamine.
    Guo L; Enzan H; Hayashi Y; Miyazaki E; Jin Y; Toi M; Kuroda N; Hiroi M
    Exp Mol Pathol; 2006 Dec; 81(3):255-61. PubMed ID: 16979622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
    Hsu YC; Chiu YT; Cheng CC; Wu CF; Lin YL; Huang YT
    J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
    Nan YM; Fu N; Wu WJ; Liang BL; Wang RQ; Zhao SX; Zhao JM; Yu J
    Scand J Gastroenterol; 2009; 44(3):358-65. PubMed ID: 18991162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of transforming growth factor-beta1/Smad3 signaling in bronchiolitis obliterans following lung transplantation].
    Liu HX; Li Y; Zhao CH; Liu Y; Zhang QG; Cong W; Lan XG; Xu S; Han LB; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(29):2069-73. PubMed ID: 17925182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis.
    Liu X; Hu H; Yin JQ
    Liver Int; 2006 Feb; 26(1):8-22. PubMed ID: 16420505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
    Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
    Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.